(Q39541598)

12 September 2017

title

Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein (English)

1 reference

12 September 2017

1 reference

human papillomavirus 16

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

Juan Liu

1

1 reference

12 September 2017

Xiao Wang

2

1 reference

12 September 2017

Gengyin Zhou

3

1 reference

12 September 2017

Hong Wang

4

1 reference

12 September 2017

Lei Xiang

5

1 reference

12 September 2017

Yizhe Cheng

6

1 reference

12 September 2017

Wenjun Liu

7

1 reference

12 September 2017

Yan Wang

8

1 reference

12 September 2017

Jihui Jia

9

1 reference

12 September 2017

Weiming Zhao

10

1 reference

12 September 2017

language of work or name

English

0 references

publication date

14 May 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

122

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

430-436

1 reference

Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

HPV-mediated cervical carcinogenesis: concepts and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Mechanisms of human papillomavirus-induced oncogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Persistence of human papillomavirus infection: keys to malignant progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

CIP2A inhibits PP2A in human malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

CIP2A is associated with human breast cancer aggressivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

CIP2A expression and localization in oral carcinoma and dysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Functions of myc:max in the control of cell proliferation and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

MYC in oncogenesis and as a target for cancer therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

ras and c-myc oncoproteins during tumor progression in the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Genetic alterations in cervical carcinomas: Frequent low-level amplifications of oncogenes are associated with human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

The c-myc activation in cervical carcinomas and HPV 16 infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.031

10.1016/J.YGYNO.2011.04.031

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference